BioSpace News Archive

Business

Eidos Therapeutics Closes on Series B Round Worth $64M

Eidos Therapeutics closed on a $64 million Series B financing round. The funds will be used to advance the company’s product candidate, AG10, into Phase II clinical trials and Phase III trials.

April 5, 2018

·

2 min read

·

Mark Terry

Business

Insulet to Announce First Quarter 2018 Financial Results on May 3, 2018

Insulet Corporation announced plans to release its financial results for the first quarter of 2018 on May 3, 2018 after the close of the financial markets.

April 5, 2018

·

1 min read

Business

Co-Diagnostics Files Initial Annual Report on Form 10-K and Updates Corporate Developments

CODX updates on initial six months as a public company

April 5, 2018

·

9 min read

Pharm Country

Orthopaedic Surgeons Offer Laser Therapy For Pain Management And Find Great Success

The first ever article featuring Cutting Edge Laser Technologies and their orthopaedic customers’ success with therapy lasers has been included in Medco Forum

April 5, 2018

·

3 min read

Pharm Country

GNC Announces Plans to Expand into Australia

General Nutrition Corporation (NYSE: GNC) today announced plans to establish and develop a presence in the Australian market.

April 5, 2018

·

2 min read

Policy

PAVmed Announces Final Results of Offer to Exchange Series W Warrants for Series Z Warrants

The Offer expired at 5:00 p.m. Eastern time on April 2, 2018.

April 5, 2018

·

3 min read

BioMidwest

Walgreens Supports Surgeon General’s Advisory on Naloxone and Opioid Overdose

In support of the advisory on naloxone and opioid overdose issued today by U.S. Surgeon General Jerome M. Adams, M.D., M.P.H., Walgreens issued a statement.

April 5, 2018

·

3 min read

Pharm Country

Diaceutics Raises $5M from WhiteRock Capital Partners and Silicon Valley Bank to Support Global Expansion

The funding will help the company increase its global footprint and international reach.

April 5, 2018

·

3 min read

Kaiku Health Raises €4.4 Million Series A Financing to Accelerate Its Digital Therapeutics Pipeline Led by Debiopharm and Tesi

Finnish digital health company Kaiku Health Oy, which provides intelligent patient monitoring software for healthcare providers across Europe, has closed a EUR4.4 million funding round.

April 5, 2018

·

2 min read

Drug Development

First Patient Treated in Pivotal Phase 3 Trial to Evaluate OTL38 in the Detection of Ovarian Cancer

The randomized, multi-center, single dose, open label, pivotal Phase 3 study in patients with ovarian cancer will assess the efficacy of OTL38 to identify additional ovarian cancer lesions not detectable by current means.

April 5, 2018

·

2 min read